Enlivex Therapeutics Ltd. (ENLV) NASDAQ
0.85
-0.0135(-1.56%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.85
-0.0135(-1.56%)
Currency In USD
| Market Cap | 32.13M |
| Enterprise Value | 30.77M |
| P/E Ratio | 0.03 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.02 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -1.35 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | 0.53 |
| Return On Equity | 2.48 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -332,000 |
| EBITDA | -14.67M |
| Net Income | 1.24B |
| Diluted EPS | 25.48 |
| Total Cash | 5.87M |
| Total Cash/Share | 0.13 |
| Total Debt | 641,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 193.24 |
| Book Value Per Share | 42.58 |
| 52-Week Change | -9.59 |
| 52-Week High | 2.1 |
| 52-Week Low | 0.66 |
| Moving Average 50 Days | 0.85 |
| Moving Average 200 Days | 0.99 |
| Average Volume | 588,157 |
| Shares Outstanding | 24.3M |
| % Held by Institutions | 8.01 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:8 |
| Last Split Date | March 06, 2019 |